Evaluation of the check-points check MDR CT103 and CT103 XL microarray kits by use of preparatory rapid cell lysis

Journal of Clinical Microbiology

Volumn 54, Issue 5, 2016, Pages 1368-1371

  Cunningham, Scott A ^a   Vasoo, Shawn ^a,b   Patel, Robin ^a  

^a MAYO CLINIC   (United States)

^b TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; CARBAPENEMASE;

ACCURACY; AMPC GENE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIOLYSIS; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONTROLLED STUDY; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GENE; GENE IDENTIFICATION; GENOTYPE; GRAM NEGATIVE BACTERIUM; MICROARRAY KIT; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SENSITIVITY AND SPECIFICITY; BACTERIAL GENE; EVALUATION STUDY; GENETICS; GENOTYPING TECHNIQUE; HUMAN; MICROARRAY ANALYSIS; MICROBIAL SENSITIVITY TEST; MULTIDRUG RESISTANCE; PROCEDURES; TIME FACTOR;

DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENES, BACTERIAL; GENOTYPING TECHNIQUES; GRAM-NEGATIVE BACTERIA; HUMANS; MICROARRAY ANALYSIS; MICROBIAL SENSITIVITY TESTS; TIME FACTORS;

EID: 84964924308     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.03302-15     Document Type: Article

References (30)

1. Nordmann P, Dortet L, Poirel L. 2012. Carbapenem resistance in Enterobacteriaceae: here is the storm! Trends Mol Med 18:263-272.
2. Schreckenberger PC, Reasius V. 2012. Phenotypic detection of β-lactamase resistance in Gram-negative bacilli: testing and interpretation guide. Loyola University Medical Center, Maywood, IL. http://www.scacm.org /PhenotypicDetectionAntibioticResistance-rev5.pdf.
3. Vasoo S, Cunningham SA, Kohner PC, Simner PJ, Mandrekar JN, Lolans K, Hayden MK, Patel R. 2013. Comparison of a novel, rapid chromogenic biochemical assay, the Carba NP test, with the modified Hodge test for detection of carbapenemase-producing Gram-negative bacilli. J Clin Microbiol 51:3097-3101. http://dx.doi.org/10.1128/JCM .00965-13.
4. Clinical and Laboratory Standards Institute. 2016. Performance standards for antimicrobial susceptibility testing; 24th informational supplement. CLSI M100-S26. Clinical and Laboratory Standards Institute, Wayne, PA.
5. Gazin M, Paasch F, Goossens H, Malhotra-Kumar S. 2012. Current trends in culture-based and molecular detection of extended-spectrum- β-lactamase-harboring and carbapenem-resistant Enterobacteriaceae. J Clin Microbiol 50:1140-1146. http://dx.doi.org/10.1128/JCM.06852-11.
6. Cunningham SA, Noorie T, Meunier D, Woodford N, Patel R. 2013. Rapid and simultaneous detection of genes encoding Klebsiella pneumoniae carbapenemase (blaKPC) and New Delhi metallo-β-lactamase (blaNDM) in Gram-negative bacilli. J Clin Microbiol 51:1269-1271. http: //dx.doi.org/10.1128/JCM.03062-12.
7. Kaase M, Szabados F, Wassill L, Gatermann SG. 2012. Detection of carbapenemases in Enterobacteriaceae by a commercial multiplex PCR. J Clin Microbiol 50:3115-3118. http://dx.doi.org/10.1128/JCM.00991-12.
8. Poirel L, Walsh TR, Cuvillier V, Nordmann P. 2011. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis 70:119-123. http://dx.doi.org/10.1016/j.diagmicrobio.2010.12.002.
9. Willemsen I, Hille L, Vrolijk A, Bergmans A, Kluytmans J. 2014. Evaluation of a commercial real-time PCR for the detection of extended spectrum β-lactamase genes. J Med Microbiol 63:540-543. http://dx.doi .org/10.1099/jmm.0.070110-0.
10. Zheng F, Sun J, Cheng C, Rui Y. 2013. The establishment of a duplex real-time PCR assay for rapid and simultaneous detection of blaNDM and blaKPC genes in bacteria. Ann Clin Microbiol Antimicrob 12:30. http://dx .doi.org/10.1186/1476-0711-12-30.
11. Ho PL, Lo WU, Yeung MK, Lin CH, Chow KH, Ang I, Tong AH, Bao JY, Lok S, Lo JY. 2011. Complete sequencing of pNDM-HK encoding NDM-1 carbapenemase from a multidrug-resistant Escherichia coli strain isolated in Hong Kong. PLoS One 6:e17989. http://dx.doi.org/10.1371 /journal.pone.0017989.
12. Card R, Zhang J, Das P, Cook C, Woodford N, Anjum MF. 2013. Evaluation of an expanded microarray for detecting antibiotic resistance genes in a broad range of Gram-negative bacterial pathogens. Antimicrob Agents Chemother 57:458-465. http://dx.doi.org/10.1128 /AAC.01223-12.
13. Lascols C, Hackel M, Hujer AM, Marshall SH, Bouchillon SK, Hoban DJ, Hawser SP, Badal RE, Bonomo RA. 2012. Using nucleic acid microarrays to perform molecular epidemiology and detect novel β-lactamases: a snapshot of extended-spectrum β-lactamases throughout the world. J Clin Microbiol 50:1632-1639. http://dx.doi.org/10.1128/JCM .06115-11.
14. Naas T, Cuzon G, Bogaerts P, Glupczynski Y, Nordmann P. 2011. Evaluation of a DNA microarray (Check-MDR CT102) for rapid detection of TEM, SHV, and CTX-M extended-spectrum β-lactamases and of KPC, OXA-48, VIM, IMP, and NDM-1 carbapenemases. J Clin Microbiol 49:1608-1613. http://dx.doi.org/10.1128/JCM.02607-10.
15. Woodford N, Warner M, Pike R, Zhang J. 2011. Evaluation of a commercial microarray to detect carbapenemase-producing Enterobacteriaceae. J Antimicrob Chemother 66:2887-2888. http://dx.doi.org/10.1093 /jac/dkr374.
16. Cuzon G, Naas T, Bogaerts P, Glupczynski Y, Nordmann P. 2012. Evaluation of a DNA microarray for the rapid detection of extendedspectrum β-lactamases (TEM, SHV and CTX-M), plasmid-mediated cephalosporinases (CMY-2-like, DHA, FOX, ACC-1, ACT/MIR and CMY-1-like/MOX) and carbapenemases (KPC, OXA-48, VIM, IMP and NDM). J Antimicrob Chemother 67:1865-1869. http://dx.doi.org /10.1093/jac/dks156.
17. Kohner PC, Robberts FJ, Cockerill FR, III, Patel R. 2009. Cephalosporin MIC distribution of extended-spectrum-β-lactamase- and pAmpCproducing Escherichia coli and Klebsiella species. J Clin Microbiol 47: 2419-2425. http://dx.doi.org/10.1128/JCM.00508-09.
18. Simner PJ, Zhanel GG, Pitout J, Tailor F, McCracken M, Mulvey MR, Lagace-Wiens PR, Adam HJ, Hoban DJ. 2011. Prevalence and characterization of extended-spectrum β-lactamase- and AmpC β-lactamase- producing Escherichia coli: results of the CANWARD 2007-2009 study. Diagn Microbiol Infect Dis 69:326-334. http://dx.doi.org /10.1016/j.diagmicrobio.2010.10.029.
19. Vasoo S, Lolans K, Li H, Prabaker K, Hayden MK. 2014. Comparison of the CHROMagar KPC, Remel Spectra CRE, and a direct ertapenem disk method for the detection of KPC-producing Enterobacteriaceae from perirectal swabs. Diagn Microbiol Infect Dis 78:356-359. http://dx.doi.org/10 .1016/j.diagmicrobio.2013.08.016.
20. Lolans K, Queenan AM, Bush K, Sahud A, Quinn JP. 2005. First nosocomial outbreak of Pseudomonas aeruginosa producing an integronborne metallo-β-lactamase (VIM-2) in the United States. Antimicrob Agents Chemother 49:3538-3540. http://dx.doi.org/10.1128/AAC.49.8 .3538-3540.2005.
21. Villegas MV, Correa A, Perez F, Zuluaga T, Radice M, Gutkind G, Casellas JM, Ayala J, Lolans K, Quinn JP. 2004. CTX-M-12 β-lactamase in a Klebsiella pneumoniae clinical isolate in Colombia. Antimicrob Agents Chemother 48:629-631. http://dx.doi.org/10.1128/AAC .48.2.629-631.2004.
22. Pattharachayakul S, Neuhauser MM, Quinn JP, Pendland SL. 2003. Extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae: activity of single versus combination agents. J Antimicrob Chemother 51:737-739. http://dx.doi.org/10.1093/jac/dkg119.
23. Johnson JR, Urban C, Weissman SJ, Jorgensen JH, Lewis JS, II, Hansen G, Edelstein PH, Robicsek A, Cleary T, Adachi J, Paterson D, Quinn J, Hanson ND, Johnston BD, Clabots C, Kuskowski MA. 2012. Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-β-lactamase-producing E. Coli from the United States, 2000 to 2009. Antimicrob Agents Chemother 56:2364-2370. http://dx.doi.org/10.1128/AAC.05824-11.
24. Pitout JD, Laupland KB, Church DL, Menard ML, Johnson JR. 2005. Virulence factors of Escherichia coli isolates that produce CTX-M-type extended-spectrum β-lactamases. Antimicrob Agents Chemother 49: 4667-4670. http://dx.doi.org/10.1128/AAC.49.11.4667-4670.2005.
25. Perez-Perez FJ, Hanson ND. 2002. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 40:2153-2162. http://dx.doi.org/10.1128/JCM.40.6.2153-2162.2002.
26. Shibata N, Kurokawa H, Doi Y, Yagi T, Yamane K, Wachino J, Suzuki S, Kimura K, Ishikawa S, Kato H, Ozawa Y, Shibayama K, Kai K, Konda T, Arakawa Y. 2006. PCR classification of CTX-M-type β-lactamase genes identified in clinically isolated Gram-negative bacilli in Japan. Antimicrob Agents Chemother 50:791-795. http://dx.doi.org/10.1128/AAC.50.2.791-795.2006.
27. Bogaerts P, Hujer AM, Naas T, de Castro RR, Endimiani A, Nordmann P, Glupczynski Y, Bonomo RA. 2011. Multicenter evaluation of a new DNA microarray for rapid detection of clinically relevant bla genes from β-lactam-resistant Gram-negative bacteria. Antimicrob Agents Chemother 55:4457-4460. http://dx.doi.org/10.1128/AAC.00353-11.
28. Juiz P, Solé M, Pitart C, Marco F, Almela M, Vila J. 2014. Detection of extended-spectrum β-lactamase- and/or carbapenemase-producing Enterobacteriaceae directly from positive blood culture using a commercialised microarray technique. Int J Antimicrob Agents 44:88-89. http: //dx.doi.org/10.1016/j.ijantimicag.2014.04.005.
29. Vasoo S, Cunningham SA, Cole NC, Kohner PC, Menon SR, Krause KM, Harris KA, De PP, Koh TH, Patel R. 2015. In vitro activities of ceftazidime-avibactam, aztreonam-avibactam, and a panel of older and contemporary antimicrobial agents against carbapenemase-producing Gram-negative bacilli. Antimicrob Agents Chemother 59:7842-7846. http://dx.doi.org/10.1128/AAC.02019-15.
30. Diekema DJ, Pfaller MA. 2013. Rapid detection of antibiotic-resistant organism carriage for infection prevention. Clin Infect Dis 56:1614-1620. http://dx.doi.org/10.1093/cid/cit038.